Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial
Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.
from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi
from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi
0 Response to "Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial"
Post a Comment